Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Ascletis Pharma, Inc.
HK$12.90
HK$14.01B
―
1454.22%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.28
HK$32.86B
34.87
135.46%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$8.54
HK$17.49B
―
251.44%
0 Buy
1 Hold
0 Sell
Hold
CARsgen Therapeutics Holdings Ltd.
HK$19.96
HK$12.93B
―
481.92%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$20.86
HK$8.84B
229.90
224.42%
0 Buy
1 Hold
0 Sell
Hold
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
66.50
31.25
88.65%
HK:1672
Ascletis Pharma, Inc.
12.90
12.05
1417.65%
HK:2096
Simcere Pharmaceutical Group Limited
13.28
7.47
128.57%
HK:2157
Lepu Biopharma Co. Ltd. Class H
8.54
5.98
233.59%
HK:2171
CARsgen Therapeutics Holdings Ltd.
19.96
16.71
514.15%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
20.86
14.43
224.42%